| Paramagnetic properties of metal-free boron-doped graphene quantum dots and their application for safe magnetic resonance imaging H Wang, MR Revia, K Wang, MRJ Kant, Q Mu, Z Gai, K Hong, M Zhang Advanced Materials (Deerfield Beach, Fla.) 29 (11), 2017 | 143 | 2017 |
| Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells Q Mu, FM Kievit, RJ Kant, G Lin, M Jeon, M Zhang Nanoscale 7 (43), 18010-18014, 2015 | 122 | 2015 |
| Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes NJ Kaiser, RJ Kant, AJ Minor, KLK Coulombe ACS biomaterials science & engineering 5 (2), 887-899, 2018 | 108 | 2018 |
| Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues RJ Kant, KLK Coulombe Acta biomaterialia 69, 42-62, 2018 | 59 | 2018 |
| Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts F Munarin, RJ Kant, CE Rupert, A Khoo, KLK Coulombe Biomaterials 251, 120033, 2020 | 43 | 2020 |
| A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues CM Kofron, TY Kim, F Munarin, AH Soepriatna, RJ Kant, U Mende, ... Scientific Reports 11 (1), 10228, 2021 | 20 | 2021 |
| Digital design and automated fabrication of bespoke collagen microfiber scaffolds NJ Kaiser, JA Bellows, RJ Kant, KLK Coulombe Tissue Engineering Part C: Methods 25 (11), 687-700, 2019 | 13 | 2019 |
| Tissues with Patterned Vessels or Protein Release Induce Vascular Chemotaxis in an In Vitro Platform RJ Kant, CF Bare, KLK Coulombe Tissue Engineering Part A 27 (19-20), 1290-1304, 2021 | 3 | 2021 |
| One billion hiPSC-cardiomyocytes: upscaling engineered cardiac tissues to create high cell density therapies for clinical translation in heart regeneration KD Dwyer, RJ Kant, AH Soepriatna, SM Roser, MC Daley, SA Sabe, ... Bioengineering 10 (5), 587, 2023 | 2 | 2023 |
| Mid-scale vessels in engineered tissue for regeneration KLK Coulombe, KD DWYER US Patent App. 18/358,808, 2024 | | 2024 |
| Abstract P1129: Directing Revascularization In Vivo With Local Controlled Release Of An Optimized Angiogenic Growth Factor Cocktail A Minor, S Roser, R Kant, K Zahiri, C Polucha, KL Coulombe Circulation Research 133 (Suppl_1), AP1129-AP1129, 2023 | | 2023 |
| Patterned Arteriole-Scale Vessels Enhance Engraftment, Perfusion, and Vessel Branching Hierarchy of Engineered Human Myocardium for Heart Regeneration RJ Kant, KD Dwyer, JH Lee, C Polucha, M Kobayashi, S Pyon, ... Cells 12 (13), 1698, 2023 | | 2023 |
| Patterned Vessels In HIPSC-derived Engineered Myocardium Enhance Perfusion And Heart Regeneration In A Rat Myocardial Infarction Model R Kant, K Dwyer, C Polucha, KL Coulombe CIRCULATION RESEARCH 131, 2022 | | 2022 |
| Abstract P1140: Scaling Up Engineered Cardiac Tissue For Clinical Translation As A Regenerative Therapy K Dwyer, R Kant, KL Coulombe Circulation Research 131 (Suppl_1), AP1140-AP1140, 2022 | | 2022 |
| Abstract P1032: Patterned Vessels In HIPSC-derived Engineered Myocardium Enhance Perfusion And Heart Regeneration In A Rat Myocardial Infarction Model R Kant, K Dwyer, C Polucha, KL Coulombe Circulation Research 131 (Suppl_1), AP1032-AP1032, 2022 | | 2022 |
| 2D and 3D Assessment of Angiogenesis in Cardiac Engineered Tissues Implanted on Infarcted Rat Hearts F Munarin, RJ Kant, CE Rupert, A Khoo, KL Coulombe Circulation Research 125 (Suppl_1), A716-A716, 2019 | | 2019 |
